Effect of Adenosine-Regulating Agent Acadesine on Morbidity and Mortality Associated With Coronary Artery Bypass Grafting. The RED-CABG Randomized Controlled Trial

Study Questions:

What is the efficacy and safety of acadesine administered in the perioperative period of coronary artery bypass grafting (CABG) in reducing all-cause mortality, nonfatal stroke, and severe left ventricular dysfunction (SLVD) through 28 days?